Further candidate inflammatory targets for treatment of MDD would include inflammatory cytokines, adhesion molecules and cellular components of the inflammatory response.63 Cytokine inhibitors (for example infliximab) target inflammatory cytokines such as TNF-α, IL-1, IL-6R, and IL-12/23 and the cell adhesion molecule α4-integrin. This evidence concerns the gene IL6R and major depressive disorder.